会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 122. 发明授权
    • 5-Epi-4,6-di-O-(aminoglycosyl)-2-deoxystreptamines, methods for their
manufacture and intermediates useful therein, methods for their use as
antibacterial agents and compositions useful therefor
    • 5-EPI-4,6-DI-O-(氨基甲酰基)-2-脱氧酪氨酸蛋白酶,其制备方法及其有用的中间体,其用作抗细菌剂及其组合物的方法
    • US4000261A
    • 1976-12-28
    • US611289
    • 1975-09-08
    • Peter J. L. Daniels
    • Peter J. L. Daniels
    • C07H15/234C07H15/236A61K31/71C07H15/22
    • C07H15/22C07H15/234C07H15/236
    • 5-Epi-4,6-di-O-(aminoglycosyl)-2-deoxystreptamines and 1-N-alkyl-5-epi-4,6-di-O-(aminoglycosyl)-2-deoxystreptamines, valuable as antibacterial agents, are prepared from the corresponding 5-O-hydrocarbonsulfonyl (or substituted hydrocarbonsulfonyl)-4,6-di-O-(aminoglycosyl)-2-deoxystreptamine wherein amino and hydroxyl functions are protected by groups susceptible to reductive cleavage or to basic or mild acid hydrolysis, by the reaction thereof with dimethylformamide at elevated temperatures, followed by removal of the protecting groups. Alternatively, 5-epi-4,6-di-O-(aminoglycosyl)-2-deoxystreptamines and their 1-N-alkyl derivatives are prepared by oxidation of the corresponding 4,6-di-O-(aminoglycosyl)-2-deoxystreptamine wherein the amino and hydroxyl functions other than the 5-hydroxyl function are protected by groups susceptible to reductive cleavage or to basic or mild acid hydrolysis, with ruthenium tetroxide, chromic acid in acetone or chromium trioxide-pyridine complex in methylene chloride, thence reaction of the thereby produced 5-dehydro-4,6-di-O-(aminoglycosyl)-2-deoxystreptamine or 1-N-alkyl derivative thereof (novel intermediates) with an alkali metal borohydride followed by removal of the amino and hydroxyl protecting groups.In addition to the foregoing, methods are described whereby the 1-N-alkyl-5-epi-4,6-di-O-(aminoglycosyl)-2-deoxystreptamines are prepared from the corresponding 1-N-unsubstituted-5-epi-4,6-di-O-(aminoglycosyl)-2-deoxystreptamines.Pharmaceutical compositions comprising 5-epi-4,6-di-O-(aminoglycosyl)-2-deoxystreptamines or 1-N-alkyl-5-epi-4,6-di-O-(aminoglycosyl)-2-deoxystreptamines elicit an antibacterial response in a warm blooded animal having a susceptible bacterial infection.